[{"type": "title", "data": "COVID-19 Nirmatrelvir-Ritonavir (Paxlovid)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Refer to NH Firstline (app.firstline.org) for eligibility guide for mild to moderate COVID-19 "}, {"type": "note", "data": "For pregnant patients contact the reproductive ID Specialist on-call and BC Women's Hospital: 604-875-2161"}, {"type": "note", "data": "nirmatrelvir-ritonavir is only appropriate for confirmed COVID-19 patients, 18 years or older who are:-mildly ill (no supplemental oxygen above baseline requirements)-within 5 days of symptom onset (symptom onset day is considered day zero)*AND* one of the following:-inadequate immune response to COVID-19 vaccine or high-risk conditions regardless of vaccine status-unimmunized and either 50 years or older or have three or more chronic conditions (listed below)-partially* immunized and 50 years or older with three or more chronic conditions (listed below)-partially* immunized and 70 years or older with one or more chronic conditions (listed below)-self-identify as Indigenous (e.g. First Nations [including status and non-status], Inuit or Metis)*partially immunized is defined as receiving one or two vaccine doses or having a previous infection alone"}, {"type": "note", "data": "Chronic conditions that increase risk for developing severe COVID-19 related complications:-hypertension/heart disease-stroke-chronic kidney disease-COPD-diabetes-neurological conditions-obesity (BMI greater than 30)-smoking"}, {"type": "note", "data": "Do NOT use nirmatrelvir-ritonavir if:-symptoms consistent with severe COVID-19 defined by shortness of breath at rest or respiratory distress and requiring supplemental oxygen-presenting greater than 5 days from symptom onset-ALT equal to or greater than 3 times the upper limit of normal-history of significant liver disease (e.g. cirrhosis, hepatitis, or severe liver dysfunction)-moderate to severe renal impairment requiring renal replacement therapy or known GFR less than 30 mL/min"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "For eGFR 60 mL/min or greater"}, {"type": "order", "data": "nirmatrelvir-ritonavir 150 mg-100 mg (300 mg-100 mg Dose) oral tablet", "value": ""}, {"type": "sentence", "data": "1 packet(s), PO, Tab, BID, 5 day(s)"}, {"type": "order", "data": "nirmatrelvir-ritonavir 150 mg-100 mg (150 mg-100 mg Dose) oral tablet", "value": ""}, {"type": "sentence", "data": "1 packet(s), PO, Tab, BID, 5 day(s)"}, {"type": "note", "data": "For eGFR 30 to 59 mL/min"}, {"type": "order", "data": "nirmatrelvir-ritonavir", "value": ""}, {"type": "sentence", "data": "1 packet(s), PO, Tab, BID, 5 day(s)"}, {"type": "note", "data": "For eGFR less than 30 mL/min or receiving renal replacement therapy: do not give"}, {"type": "category", "data": "Laboratory"}, {"type": "note", "data": "Obtain baseline lab work if not done within last 6 months: "}, {"type": "order", "data": "ALT", "value": ""}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "order", "data": "Creatinine", "value": ""}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}]
